Abstract

Positive-sense RNA viruses hijack intracellular membranes that provide niches for viral RNA synthesis and a platform for interactions with host proteins. However, little is known about host factors at the interface between replicase complexes and the host cytoplasm. We engineered a biotin ligase into a coronaviral replication/transcription complex (RTC) and identified >500 host proteins constituting the RTC microenvironment. siRNA-silencing of each RTC-proximal host factor demonstrated importance of vesicular trafficking pathways, ubiquitin-dependent and autophagy-related processes, and translation initiation factors. Notably, detection of translation initiation factors at the RTC was instrumental to visualize and demonstrate active translation proximal to replication complexes of several coronaviruses. Collectively, we establish a spatial link between viral RNA synthesis and diverse host factors of unprecedented breadth. Our data may serve as a paradigm for other positive-strand RNA viruses and provide a starting point for a comprehensive analysis of critical virus-host interactions that represent targets for therapeutic intervention.

Data availability

The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD009975.All other data generated or analysed during this study are included in the manuscript and supporting files.

The following data sets were generated

Article and author information

Author details

  1. Philip V'kovski

    Institute of Virology and Immunology IVI, Bern, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8366-1220
  2. Markus Gerber

    Institute of Virology and Immunology IVI, Bern, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  3. Jenna Kelly

    Institute of Virology and Immunology IVI, Bern, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  4. Stephanie Pfaender

    Institute of Virology and Immunology IVI, Bern, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  5. Nadine Ebert

    Institute of Virology and Immunology IVI, Bern, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  6. Sophie Braga Lagache

    Mass Spectrometry and Proteomics Core Facility, Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  7. Cedric Simillion

    Mass Spectrometry and Proteomics Core Facility, Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  8. Jasmine Portmann

    Institute of Virology and Immunology IVI, Bern, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  9. Hanspeter Stalder

    Institute of Virology and Immunology IVI, Bern, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  10. Véronique Gaschen

    Division Veterinary Anatomy, University of Bern, Bern, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  11. Rémy Bruggmann

    Interfaculty Bioinformatics Unit, University of Bern, Bern, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4733-7922
  12. Michael H Stoffel

    Division of Veterinary Anatomy, University of Bern, Bern, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4699-5125
  13. Manfred Heller

    Mass Spectrometry and Proteomics Core Facility, Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  14. Ronald Dijkman Dijkman

    Institute of Virology and Immunology IVI, Bern, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  15. Volker Thiel

    Institute of Virology and Immunology IVI, Bern, Switzerland
    For correspondence
    volker.thiel@vetsuisse.unibe.ch
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5783-0887

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (173085)

  • Philip V'kovski
  • Volker Thiel

European Commission (748627)

  • Stephanie Pfaender
  • Volker Thiel

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (160780)

  • Jenna Kelly
  • Nadine Ebert
  • Volker Thiel

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2019, V'kovski et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 11,185
    views
  • 1,687
    downloads
  • 145
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Philip V'kovski
  2. Markus Gerber
  3. Jenna Kelly
  4. Stephanie Pfaender
  5. Nadine Ebert
  6. Sophie Braga Lagache
  7. Cedric Simillion
  8. Jasmine Portmann
  9. Hanspeter Stalder
  10. Véronique Gaschen
  11. Rémy Bruggmann
  12. Michael H Stoffel
  13. Manfred Heller
  14. Ronald Dijkman Dijkman
  15. Volker Thiel
(2019)
Determination of host proteins composing the microenvironment of coronavirus replicase complexes by proximity-labeling
eLife 8:e42037.
https://doi.org/10.7554/eLife.42037

Share this article

https://doi.org/10.7554/eLife.42037

Further reading

    1. Immunology and Inflammation
    2. Microbiology and Infectious Disease
    Yan Zhao, Hanshuo Zhu ... Li Sun
    Research Article

    Type III secretion system (T3SS) is a virulence apparatus existing in many bacterial pathogens. Structurally, T3SS consists of the base, needle, tip, and translocon. The NLRC4 inflammasome is the major receptor for T3SS needle and basal rod proteins. Whether other T3SS components are recognized by NLRC4 is unclear. In this study, using Edwardsiella tarda as a model intracellular pathogen, we examined T3SS−inflammasome interaction and its effect on cell death. E. tarda induced pyroptosis in a manner that required the bacterial translocon and the host inflammasome proteins of NLRC4, NLRP3, ASC, and caspase 1/4. The translocon protein EseB triggered NLRC4/NAIP-mediated pyroptosis by binding NAIP via its C-terminal region, particularly the terminal 6 residues (T6R). EseB homologs exist widely in T3SS-positive bacteria and share high identities in T6R. Like E. tarda EseB, all of the representatives of the EseB homologs exhibited T6R-dependent NLRC4 activation ability. Together these results revealed the function and molecular mechanism of EseB to induce host cell pyroptosis and suggested a highly conserved inflammasome-activation mechanism of T3SS translocon in bacterial pathogens.

    1. Microbiology and Infectious Disease
    Julia A Hotinger, Ian W Campbell ... Matthew K Waldor
    Research Article

    Murine models are often used to study the pathogenicity and dissemination of the enteric pathogen Salmonella enterica serovar Typhimurium. Here, we quantified S. Typhimurium population dynamics in mice using the STAMPR analytic pipeline and a highly diverse S. Typhimurium barcoded library containing ~55,000 unique strains distinguishable by genomic barcodes by enumerating S. Typhimurium founding populations and deciphering routes of spread in mice. We found that a severe bottleneck allowed only one in a million cells from an oral inoculum to establish a niche in the intestine. Furthermore, we observed compartmentalization of pathogen populations throughout the intestine, with few barcodes shared between intestinal segments and feces. This severe bottleneck widened and compartmentalization was reduced after streptomycin treatment, suggesting the microbiota plays a key role in restricting the pathogen’s colonization and movement within the intestine. Additionally, there was minimal sharing between the intestine and extraintestinal organ populations, indicating dissemination to extraintestinal sites occurs rapidly, before substantial pathogen expansion in the intestine. Bypassing the intestinal bottleneck by inoculating mice via intravenous or intraperitoneal injection revealed that Salmonella re-enters the intestine after establishing niches in extraintestinal sites by at least two distinct pathways. One pathway results in a diverse intestinal population. The other re-seeding pathway is through the bile, where the pathogen is often clonal, leading to clonal intestinal populations and correlates with gallbladder pathology. Together, these findings deepen our understanding of Salmonella population dynamics.